Comparison of Efficacy and Side Effect Between Albendazole, Albendazole-Levamisole and Mebendazole-Levamisole Againts Soil-Transmitted Helminths Infection at a Public Elementary School-Age Children on The Deli Serdang Regency
Abstract
Intestinal worm infection in particular of Soil Transmitted Helminth is still a global problem with high prevalence on the tropic and subtropic regions including Indonesia especially in the rural community. Double Blind Randomized Trial that started from April to June 2015 in which the samples are collected from public elementary school children on the Deli Serdang Regency to compare the effectivity and side effect of STH infection treatment by using Albendazole 400 mg, Albendazole 400 mg-Levamisol 50 mg/100 mg, Mebendazole 500 mg-Levamisol 50 mg/100 mg. The samples of Albendazole, Albendazole-Levamisol and Mebendazole-Levamisol groups consist of 60 children in each group in which the ones that have STH infection are Ascariasis 92 children 51.11%, Trichuriasis 37 children 20.55%, and mixed infection 51 children 28.33%. In this research, researcher doesn’t found hookworm infection in any of the groups. From the result of
stool examination, researcher found 100% of cure rate for A. lumbricoides infection on all groups, cure rate of T. trichiura infection 66.7%, 94.7%, 92.3% for each Albendazole, Albendazole-Levamisol, and Mebendazole-Levamisol groups meanwhile cure rate for mixed infection are 28.6%, 85.7%, and 66.7% for each Albendazole, Albendazole-Levamisoland Mebendazole- Levamisol groups. For mild T.trichiura infection treatment with singledose of Albendazole-Levamisol
group is better than both of Albendazole and Mebendazole- Levamisole groups (p=0.01). In this research, researcher found nausea and diarrhea as treatment of side effect and no signifi cant difference of side effect in all groups of treatment.
References
2. Soedarto. Parasitologi Klinik. Cetakan Pertama. Airlangga University Press. 2008. 83-86.
3. Steinmann P, Utzinger J, Du Z–W, Jiang J-Y, Chen J-X,et at. Efficacy of singel-dose and triple-dose albendazole and mebendazole against soil-transmitted helminths and taenia spp.; A randomized controlled trial. Plos ONE 6 (9); e25003. 2011.
4. WHO. Shistomiasis and soil-transmitted helminths infection-preliminary estimates of the number of children treated with albendazole or mebendazole. Weekly-Epidiomedical Recerd. 2006. 16:145-146.
5. Olliaro P, Seiler J, Kuesel A, Horton J, Clark JN, Keiser J, et al. Potential drug development candidates for human soil-transmitted helminthiases. PLoS Neglected Tropical Diseases 5(6): e1138. 2011.
6. Amelia F, Ali M, Pasaribu S. Mebendazole vs Mebendozole-Pyrantel Pamoate for soil-transmitted helminthiasis infection in children. Pediatrica Indonesiana; 2013. 53: 209-13.
7. Pasaribu S. Penentuan frekuensi optimal pengobatan massal askariasis dengan albendazole pada anak usia sekolah dasar dengan pendekatan model dinamika populasi cacing. Tesis Doctor. Program Pasca Sarjana USU. Medan. 2003.
8. WHO. Report of the WHO informal consultation on the use of chemotherapy for the control of morbidity due to soil-transmitted nematodes in humans. Division of Control of Tropical Diseases. Geneva. 1996.
9. Bertram GK. Farmakologi Dasar Klinis. Bagian Farmakologi Fakultas Kedokteran Universitas Airlangga. Penerbit Salemba Medika. Mc Graw Hill. Edisi 8. 2004. 261-269.
10. Sukarban S, dan Santoso SO. Antelmintik. Dalam: Ganiswarna, SG, Setiabudy R, Suyatna FD, Purwantyastuti dan Nafrialdi. (penyunting) Farmakologi dan Terapi. Ed. Keempat. Penerbit Bagian Farmakologi FK UI. Jakarta. 2001. 523-36.
11. Tjay TH, dan Rahardja K. Obat-Obat Penting, Khasiat, Penggunaan, dan Efek-Efek Sampingnya. Ed. Keenam. Penerbit PT Elex Media Komputindo. Jakarta. 2008. 196-207.
12. Keiser J, Utzinger J. Effi cacy of current drugs against soil-transmitted helminth infection, systemic review and meta-analysis. JAMA; 299. 2008. 1937-48.
13. Lubis IND. Pengaruh albendazole dan mebendazole pada sterilitas telur ascariasis lumbricoides. [tesis]. Medan : Universitas Sumatera Utara. 2009.
14. MenKes RI. Pedoman pengendalian cacing. MenKes RI. Jakarta. 2006.
15. WHO. WHO Model Prescribing Information. Drug used in parasitic diseases. Geneva. 1995.
16. Hall A, Nahar Q. Albendazole and infections with Ascaris lumbricoides and Trichuris trichiura in children in Bangladesh. Trans R. Soc. Trop. Med. Hyg.; 4. 1994.118-236.
17. World Health Organization. Soil-transmitted helminthiasis: Number of Children Treated in 2010. Bull World Health Organ. 2012.
18. World Health Organization. Research priorites for helminth infections. WHO Technical Report Series. World of Health Organization Bulletin; 14. 2012.
19. Knopp S, Mohammed KA, Speich B, Hattendorf J, Khamis IS, Khamis AN, et al. Albendazole and mebendazole administered alone or in combination with ivermectin against Trichuris trichiura : A randomized controlled trial. Clinical Infectious Diseases; 51(12). 2010. 1420-1428.
20. Lubis IND, Pasaribu S, Lubis CP. Current status of the effi cacy, and effectiveness of albendazole and mebendazole for the treatment of Ascaris lumbricoides in North –Western Indonesia; Asian Pacifi k Journal of Tropical Medicine. 2012. 605-609.
21. Saputri D. Perbandingan efikasi dosis tunggal mebendazol dengan dan tanpa levamisol terhadap soil-transmitted helminths pada anak usia sekolah dasar [tesis]. Medan: Universitas Sumatera Utara. 2009.
22. Sihite IF, W.S, Ali M., Pasaribu AP, Pasaribu S, Lubis CP. Effi cacy of mebendazole and levamisole, alone or in combination, for soil-transmitted helminthiasis. Pediatrica Indonesiana; 54. 2014. 9-14.
23. Sukarban S, dan Santoso SO. Antelmintik. Dalam: Ganiswarna SG, Setiabudy R, Suyatna FD, Purwantyastuti dan Nafrialdi. (penyunting) Farmakologi dan Terapi. Ed. Keempat. Penerbit Bagian.
Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.
This licence applies to Author(s) and Public Reader means that the users mays :
- SHARE:
copy and redistribute the article in any medium or format - ADAPT:
remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication) - ALIKE:
If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original. - NO ADDITIONAL RESTRICTIONS:
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
It does however mean that when you use it you must:
- ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
You may not:
- NONCOMMERCIAL: You may not use the article for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Tools
